HPV infection with 'high-risk'genotypes is associated with ano-genital and oropharyngeal
cancers. Two currently licensed prophylactic HPV vaccines designed to prevent disease …

When HPV vaccines were registered in 2006/2007, it was unclear whether these new and
type-specific prophylactic vaccines would be accepted by the community for cancer …

This issue of the journal presents a milestone in expanding coverage against cancers
associated with human papillomavirus (HPV). Joura and coauthors' report of a randomized …

Human papillomavirus (HPV)-related diseases, including cancers, low-grade neoplasia,
genital warts, and recurrent respiratory papillomatosis, have a substantial impact on public …

The clinical burden of disease resulting from human papillomavirus (HPV) infection is
substantial and extends from genital warts to cytologic abnormalities to cervical, vaginal, and …

Persistent infection with oncogenic human papillomavirus (HPV) is a necessary cause of
cervical cancer. Moreover, HPV type 16 (and to a lesser degree HPV type 18) is linked with …

Human papillomavirus (HPV) is a necessary, though not sufficient, cause of cervical cancer.
Two vaccines have been developed that prevent two HPV types associated with 70% of …

Cervical cancer is a malignant neoplasm arising from cells that originate in the cervix uteri. It
is the second most prevalent cancer among women. It can have several causes; an infection …

Human papillomavirus (HPV) infection is common and causes a wide spectrum of disease.
With recent advances in the development of prophylactic HPV vaccines, it is likely that these …

Background There are over 100 different types of human papillomavirus (HPV), and many
have been linked to cancers and benign lesions of the anogenital tract, head, and neck. In …